Trial Profile
Phase II Interstitial Brachytherapy Combined With Androgen Deprivation Therapy [bicalutamide + leuprorelin] for Locally Recurrent Prostate Cancer After Prior External Beam Irradiation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary) ; Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 13 May 2011 Planned end date changed from 1 Apr 2025 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 13 May 2011 Planned end date changed from 1 Apr 2025 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 18 Jun 2008 New trial record.